Revised Proxy Soliciting Materials (definitive) (defr14a)
May 08 2020 - 6:12AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934
(Amendment
No. 1)
Filed
by the Registrant ☒
Filed
by a Party other than the Registrant ☐
Check
the appropriate box:
☐
Preliminary Proxy Statement
☐
Confidential, For Use of the Commission Only (As Permitted by Rule
14a-6(e)(2))
☒
Definitive Proxy Statement
☐
Definitive Additional Materials
☐
Soliciting Material under Rule 14a-12
Cellular Biomedicine Group, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the
Registrant)
Payment
of Filing Fee (Check the appropriate box):
☒
No fee required
☐
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and
0-11.
(1)
Title of each class of securities to which transaction
applies:
(2)
Aggregate number of securities to which transaction
applies:
(3) Per
unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which
the filing fee is calculated and state how it was
determined):
(4)
Proposed maximum aggregate value of transaction:
(5)
Total fee paid:
☐
Fee paid previously with preliminary materials.
☐
Check box if any part of the fee is offset as provided by Exchange
Act Rule 0-11(a)(2) and identify the filing for which the
offsetting fee was paid previously. Identify the previous filing by
registration statement number, or the form or schedule and the date
of its filing.
(1)
Amount Previously Paid:
(2)
Form, Schedule or Registration Statement No.:
(3)
Filing Party:
(4)
Date Filed:
EXPLANATORY NOTE
Cellular
Biomedicine Group, Inc. (the “Company”) is filing this
amendment solely to replace the sample proxy card included in the
Definitive Proxy Statement filed by the Company with the Securities
and Exchange Commission on April 29, 2020 (the “Proxy
Statement”). Due to a clerical error, an incorrect version of
the sample proxy card was filed with the Proxy Statement. The
correct version of the sample proxy card is included
below.
Please
note that no changes have been made to the body of the Proxy
Statement and that a correct version of the proxy card has been
included in the Proxy Statement being mailed to the Company’s
stockholders. This amendment applies only to the EDGAR version of
the sample proxy card originally filed with the Proxy
Statement.
CELLULAR BIOMEDICINE GROUP, INC.
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF
DIRECTORS
ANNUAL MEETING OF STOCKHOLDERS – JUNE 26, 2020 AT 9:00 AM
EST
|
|
|
CONTROL ID:
|
|
|
|
|
|
REQUEST ID:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The undersigned hereby appoint(s) Tony (Bizuo) Liu and Andrew Chan,
or either one of them, with the power of substitution and
resubstitution to vote any and all shares of capital stock of
Cellular Biomedicine Group, Inc. (the “Company”) which
the undersigned would be entitled to vote as fully as the
undersigned could do if personally present at the Annual Meeting of
the Company, to be held on June 26, 2020, at 9:00 A.M. Eastern
Standard Time, and at any adjournments thereof, hereby revoking any
prior proxies to vote said stock, upon the following items more
fully described in the notice of any proxy statement for the Annual
Meeting (receipt of which is hereby acknowledged):
This proxy, when properly executed, will be voted in the manner
directed herein. If no such direction is made, this proxy will
be voted in accordance with the Board of Directors
recommendations.
|
|
|
(CONTINUED AND TO BE SIGNED ON REVERSE SIDE.)
|
|
|
|
|
|
|
|
|
|
VOTING INSTRUCTIONS
|
|
|
|
If you vote by phone, fax or internet, please DO NOT mail your
proxy card.
|
|
|
|
|
|
|
|
|
|
|
|
MAIL:
|
Please
mark, sign, date, and return this Proxy Card promptly using the
enclosed envelope.
|
|
|
FAX:
|
Complete
the reverse portion of this Proxy Card and Fax to 202-521-3464.
|
|
|
INTERNET:
|
https://www.iproxydirect.com/CBMG
|
|
|
PHONE:
|
1-866-752-VOTE
(8683)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ANNUAL MEETING OF THE STOCKHOLDERS OF
CELLULAR
BIOMEDICINE GROUP, INC.
|
PLEASE
COMPLETE, DATE, SIGN AND RETURN PROMPTLY IN THE ENCLOSED
ENVELOPE.
PLEASE
MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE:
☒
|
PROXY SOLICITED ON
BEHALF OF THE BOARD OF DIRECTORS
|
|
|
|
|
|
Proposal
1
|
|
FOR
ALL
|
|
WITHHOLD
ALL
|
|
FOR
ALL
EXCEPT
|
|
|
|
|
Election of
Directors
|
|
☐
|
|
☐
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chun Kwok Alan Au
|
|
|
|
|
|
☐
|
|
CONTROL
ID:
|
|
|
Jacky (Gang) Ji
|
|
|
|
|
|
☐
|
|
REQUEST
ID:
|
|
|
Tony
(Bizuo) Liu
|
|
|
|
|
|
☐
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proposal
2
|
|
FOR
|
|
AGAINST
|
|
ABSTAIN
|
|
|
|
|
To ratify the appointment of BDO China Shu Lun Pan Certified Public
Accountants LLP as the Company’s independent registered
public accounting firm for the fiscal year ending December 31,
2020.
|
|
☐
|
|
☐
|
|
☐
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proposal
3
|
|
FOR
|
|
AGAINST
|
|
ABSTAIN
|
|
|
|
|
To approve, by a
non-binding vote, the compensation of the Company’s named
executive officers.
|
|
☐
|
|
☐
|
|
☐
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proposal
4
|
|
3
YEARS
|
|
2
YEARS
|
|
1
YEAR
|
|
ABSTAIN
|
|
|
To approve, by a
non-binding vote, the frequency of future stockholder advisory
votes on the compensation of the Company’s named executive
officers.
|
|
☐
|
|
☐
|
|
☐
|
|
☐
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MARK “X” HERE IF YOU PLAN TO ATTEND THE MEETING:
☐
|
THIS PROXY WILL BE VOTED AS SPECIFIED ABOVE; UNLESS OTHERWISE
INDICATED, THIS PROXY WILL BE VOTED FOR EACH OF THE NOMINEES ON
PROPOSAL NUMBER 1, FOR APPROVAL ON PROPOSALS NUMBER 2 AND 3, AND
FOR THREE YEARS ON PROPOSAL NUMBER 4.
In their discretion, the Proxies are authorized to vote upon such
other business as may properly come before the
meeting.
Please mark, sign, date and return this Proxy promptly using the
accompanying postage pre-paid envelope. THIS PROXY IS SOLICITED ON
BEHALF OF THE BOARD OF DIRECTORS OF CELLULAR BIOMEDICINE GROUP,
INC.
|
|
MARK
HERE FOR ADDRESS CHANGE ☐ New Address
(if applicable):
____________________________
____________________________
____________________________
IMPORTANT: Please sign exactly as your
name or names appear on this Proxy. When shares are held jointly,
each holder should sign. When signing as executor, administrator,
attorney, trustee or guardian, please give full title as such. If
the signer is a corporation, please sign full corporate name by
duly authorized officer, giving full title as such. If signer is a
partnership, please sign in partnership name by authorized
person.
Dated:
________________________, 2020
|
|
|
|
(Print
Name of Stockholder and/or Joint Tenant)
|
|
(Signature
of Stockholder)
|
|
(Second
Signature if held jointly)
|
Cellular Biomedicine (NASDAQ:CBMG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cellular Biomedicine (NASDAQ:CBMG)
Historical Stock Chart
From Apr 2023 to Apr 2024